Financing ·
Telomir Pharmaceuticals raises $5.6M in PIPE at $1.16 per share, led by John Paul DeJoria
TELOTelomir Pharmaceuticals, Inc.
Telomir Pharmaceuticals raised approximately $5.6 million through a private placement of 4,843,300 shares of common stock at $1.16 per share. The transaction closed on October 5, 2026, and includes an additional $1.0 million investment from existing significant shareholder John Paul DeJoria. Proceeds will primarily support the clinical development of Telomir-Zn in triple-negative breast cancer and general corporate purposes. Alexander Capital acted as placement agent for the offering.